# The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

> **NCT03918798** · PHASE2 · COMPLETED · sponsor: **Sintetica SA** · enrollment: 164 (actual)

## Conditions studied

- Hernia, Inguinal
- Flat Foot

## Interventions

- **DRUG:** Chloroprocaine 1% Injectable Solution
- **DRUG:** Chloroprocaine 2% Injectable Solution

## Key facts

- **NCT ID:** NCT03918798
- **Lead sponsor:** Sintetica SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-14
- **Primary completion:** 2025-10-17
- **Final completion:** 2025-10-17
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03918798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03918798, "The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT03918798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*